Ideas catalog
Every idea we've derived from recent research — the ones marked “Prototype” come with a live demo you can try.
A high-potential clinical tool that is currently undermined by a critical mismatch between the theoretical mathematical model provided and the practical biological data required for implementation.
A narrow, low-complexity alert service that leverages existing local air quality data, though it lacks a strong commercial moat and relies on a single data source.
Mechanistically sharp companion diagnostic concept riding the GLP-1RA wave, but the commercial thesis rests almost entirely on mouse knockout data with only indirect human metabolite evidence, leaving a large clinical-validation gap before any CDx submission is conceivable.
Backed by 2 papers
A mechanistically novel companion diagnostic concept addressing a real unmet need in the massive GLP-1RA market, but it rests almost entirely on mouse knockout models and a single human SNP association—both far from the prospective clinical validation needed to make a diagnostic claim in humans.
Backed by 2 papers
A high-friction hardware retrofit that addresses a looming regulatory cliff (EURO 7), though it faces significant engineering hurdles regarding vehicle aerodynamics and maintenance.
Backed by 3 papers
A focused digital therapeutic for gambling addiction that translates established cognitive restructuring techniques into a scalable app, though it relies on aging research.
A highly specialized clinical tool for a very small patient population that addresses a critical safety gap, though it lacks a clear software/product moat.
A highly specialized diagnostic tool with strong scientific grounding but severe practical bottlenecks due to the cost and accessibility of longitudinal fMRI.
A high-cost, high-friction diagnostic tool that leverages strong neuroimaging evidence but faces severe scalability and clinical adoption hurdles.
A niche personalized nutrition play that leverages a specific genetic marker to sell supplements to plant-based athletes, though it relies on a single mouse-study paper for its core premise.
A niche linguistic optimization tool that addresses a specific phonetic shift in Italian, though its commercial value is limited by the ability of modern end-to-end ASR models to learn these patterns implicitly.
A low-moat content curation play that attempts to monetize open-access academic data for a high-end corporate audience.
A niche academic tool that lacks a clear commercial driver, as conservation priorities are typically driven by current threats rather than deep-time geological history.
A highly specific infrastructure play that leverages a narrow efficiency window to decarbonize a critical industrial corridor, though it functions more as a consultancy project than a scalable product.
A focused, clinically validated AI plug-in for standardizing midpalatal suture maturation scoring—a real diagnostic pain point—but it solves a narrow sub-problem that fits better as a feature inside larger imaging platforms than as a standalone venture.
Backed by 2 papers
A niche but viable optimization for automotive HVAC that leverages federated learning to balance personalization with privacy, though it faces high integration hurdles.
A high-impact public health play that leverages a strong evidence base but faces significant headwinds due to the misalignment of incentives between government regulators and automotive manufacturers.
A focused and novel location-biased pharmacology concept with real commercial upside, but the two cited papers partially contradict each other on whether 5-HT2A is necessary for plasticity at all, and achieving in-vivo selectivity for intracellular vs. surface pools of the same GPCR is a formidable unsolved chemistry problem.
Backed by 2 papers
A niche HR training tool that translates a small-scale academic study into a corporate compliance product, though it faces significant headwinds regarding buyer urgency and scalability.
A generic compliance wrapper that lacks a proprietary technical edge and relies on a broad survey rather than a specific breakthrough.